Patterns of managing chronic hepatitis B treatment-related drug resistance: a survey of physicians in Mainland China, South Korea, Taiwan, and Thailand
Siwaporn Chainuvati(Siriraj Hospital), Xin Xin Zhang(Shanghai Institute of Hematology), Chao‐Wei Hsu, Cheng‐Yuan Peng(China Medical University), Tawesak Tanwandee(Siriraj Hospital), Piyawat Komolmit(Thai Red Cross Society), Ming‐Lung Yu(National Sun Yat-sen University), Chun‐Jen Liu(National Taiwan University), Jin Hou(Nanfang Hospital), B. Neo(Bristol-Myers Squibb (Germany)), Hong Li(Henan Agricultural University), Ying Li(Jiangsu University), Jun Cheng(Central South University), So Young Kwon(Konkuk University Medical Center), Jaw Ching Wu(Taipei Veterans General Hospital), Chang Hong Lee(Konkuk University), Ji Dong Jia(Capital Medical University), Suchat Wongcharatrawee(Bristol-Myers Squibb (United States))
Cited by 9
Related Papers
Mitotic and G <sub>2</sub> Checkpoint Control: Regulation of 14-3-3 Protein Binding by Phosphorylation of Cdc25C on Serine-216
|Science|1997|1.3k
SIRveNIB: Selective Internal Radiation Therapy Versus Sorafenib in Asia-Pacific Patients With Hepatocellular Carcinoma
|Journal of Clinical Oncology|2018|653
Hepatitis B Virus Genotype and DNA Level and Hepatocellular Carcinoma: A Prospective Study in Men
|JNCI Journal of the National Cancer Institute|2005|569
Metabolic Factors and Risk of Hepatocellular Carcinoma by Chronic Hepatitis B/C Infection: A Follow-up Study in Taiwan
|Gastroenterology|2008|552
Oral Ganciclovir for Patients with Cytomegalovirus Retinitis Treated with a Ganciclovir Implant
|New England Journal of Medicine|1999|485